Inclusion of Subjects who are Obese in Drug Development: Current Status and Opportunities

The prevalence of obesity has grown tremendously in recent years and this population has an increased risk of disease comorbidities. The presence of disease comorbidities requires treatment interventions and proper dosing guidelines. However, drug development programs often do not have adequate repr...

Full description

Bibliographic Details

Published in:	Journal of clinical pharmacology Vol. 63; no. S2; pp. S10 - S17
Main Authors:	Vaidyanathan, Jayabharathi, Fletcher, Elimika Pfuma, Ramamoorthy, Anuradha, Madabushi, Rajanikanth, Burckart, Gilbert J.
Format:	Journal Article
Language:	English
Published:	Rockville Wiley Subscription Services, Inc 01.11.2023
Subjects:	Clinical trials Comorbidity Dosage Drug development Drug dosages Obesity Patients Pediatrics Risk assessment
ISSN:	0091-2700, 1552-4604, 1552-4604
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!